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Table 1 Intrathecal infusion regimen.
Day of treatment Regimen, dose
Day 1 Colistin 20 000 IU
Day 2 Colistin 40 000 IU
Day 3 Colistin 60 000 IU
Day 4 Colistin 60 000 IU
Days 5—15 Colistin 30 000 IU
Days 16, 18, 20,
22, 24, 26
Colistin 60 000 IU plus
Vancomycin 20 mgIn this case, intravenous and intrathecal colistin
infusions were tolerated well and without any ser-
ious adverse effects. The intrathecal infusion regi-
men was decided according to the company’s
recommendations, with some necessary modifica-
tions due to early signs of reversible neurotoxicity.
One year later the patient is very well, with no
residual neurological manifestations.
In conclusion, intravenous and intrathecal colis-
tin may be a good therapeutic option in the treat-
ment of meningitis due to multidrug-resistant P.
aeruginosa.
Conflict of interest: No conflict of interest to
declare.
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Brucellosis is a widespread disease especially in
countries where infection in animals has not been
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losis is a notifiable disease in Turkey, the true inci-
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doi:10.1016/j.ijid.2005.03.005ken in our country, however, there have been no
studies on the prevalence of brucellosis in Kayseri.
This cross-sectional research was performed on 1850
individuals living in the Kayseri rural region in 2001.
People aged from 15 to 85 in nine districts were
interviewed, and blood samples were screened by
the Rose Bengal test.4
In our study, 3.4% of the total 1850 people were
found to be positive for Brucella (Table 1). The pre-
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valence in our study was found to be lower than that
in studies carried out in other regions of Turkey.5,6
The reason for this lower prevalence in Kayseri might
be due to the fact that the other studies were cond-
ucted in regions where raising livestock for commer-
cial purposes is more widespread. Another reason for
the lower results in Kayseri might be the ‘‘Turkish
Brucellosis Challenge Project’’ programme of the
Ministry of Agriculture that has been in force since
1984.7
No significant difference was found between age
groups. The prevalence was highest in the 35—44
year-olds, which might be explained by the higher
rates of animal rearing in this age group. Brucellosis
is not a gender-related disease.8,9 However, more
men are generally hired for animal-related jobs,
which might be the reason for the usually higher
brucellosis prevalence in men. In our study, while
women had a slightly higher prevalence than men,
the difference was not significant. The fact that
women are mostly responsible for the raising of
animals might explain the high seropositivity rates
in women in Kayseri. Seropositivity rates were
significantly higher in people with a family history
of brucellosis. This could be due to the shared
environment, dairy product production and con-
sumption habits, and having inadequate veterinary
controls for their animals. Seropositivity was sig-
Table 1 Prevalence of brucellosis according to several variables.
Variables Total screened (N) Brucella positive (N) % x2 p
Total 1850 62 3.4
Age groups
15—24 345 14 4.1 3.62 >0.05
25—34 394 8 2.0
35—44 376 16 4.3
45 and over 735 24 3.3
Gender
Male 857 23 2.7 2.19 >0.05
Female 993 39 3.9
History of brucellosis in the family
Present 183 12 6.6 6.44 <0.05
Absent 1667 50 3.0
Educational level
Illiterate 532 29 5.5 11.09 <0.01
Primary school 923 26 2.8
Secondary school and above 395 7 1.8
Raising livestock at home
Yes 1021 47 4.6 11.02 <0.01
No 829 15 1.8
Using common entrance for stable and home
Yes 146 16 11.0 14.03 <0.01
No 875 31 3.5
Direct contact with livestock
Yes 825 45 5.5 6.12 <0.05
No 196 2 1.0
Way of milking (n = 830)
With bare hands 794 42 5.5 0.33 >0.05
With gloves or machine 66 2 3.0
Cleaning of stables
Yes 791 43 5.4 4.74 <0.05
No 1059 4 0.4
Preparing dried cow dung
Yes 589 36 6.1 6.43 <0.05
No 1261 11 0.9
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nificantly higher in the least-educated group. This
could be related to the fact that people dealing
more with animals are less well educated, and
hence do not take the necessary preventive mea-
sures. It would also explain the higher prevalence
in women due to the low education levels in women
in our research group. Brucella positivity rates
were found to be higher in people who rear live-
stock at home, where a common entrance for
stable and home is used, where there is direct
contact with livestock, and in those who clean
stables and prepare dried cow dung.
In many studies, brucellosis rates are higher in
those who deal with livestock.3,10 The prevalence
was also found to be significantly higher in people
who stated that they make cheese, butter and
cream with raw milk in our study. We have con-
cluded that although seropositivity rates are low in
the general population, exposure to brucellosis is
high among people dealing with livestock and con-
suming raw milk and milk products. We think that
health education is essential for the success of any
prevention and control activities and should form an
integral part in all phases of public health pro-
grammes.
Conflict of interest: No conflict of interest.
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Symptomatic nosocomial urinary tract infection
in very elderly patients
Urinary tract infection (UTI) is the most frequent
hospital-acquired infection,1—3 and its risk is higher
in extreme age.4 Although very elderly patients are
considered a high-risk group for nosocomial UTI
(NUTI),5 its real risk is unknown. We therefore
conducted a prospective study in patients aged
80 years or older to determine the incidence of
NUTI and associated bacteremia, their associated
risk factors, their microbiological profiles and their
evolution.
Patients aged 80 years and over with urinary
symptoms (dysuria, frequency or urgency) or fever
and a positive urine culture obtained at least
48 hours after hospitalization, were included. These
patients were identified by members of staff.
Cultures were performed according to standard
methods. UTI, polymicrobial UTI and associated
bacteremia have previously been defined.6
Several variables were analysed including the
presence of underlying diseases, risk factors, ana-
lytic parameters and outcome. The McCabe and
Jackson criteria were used as comorbidity index.7
The study was performed in two internal medicine
